IDN5243
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IDN5243, covering 2025-07-22 to 2025-07-22. Get the full timeline:
Most recent: Clinical Trial Update: Tolerability, Safety and Activity of a Muscle Relaxant Molecule IDN5243 in Patients With Low Back Pain [Phase 2]